"Terfenadine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
Descriptor ID |
D016593
|
MeSH Number(s) |
D02.455.426.559.389.115.800 D03.383.621.855
|
Concept/Terms |
Terfenadine- Terfenadine
- Terfenidine
- alpha-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperdinebutanol
|
Below are MeSH descriptors whose meaning is more general than "Terfenadine".
Below are MeSH descriptors whose meaning is more specific than "Terfenadine".
This graph shows the total number of publications written about "Terfenadine" by people in this website by year, and whether "Terfenadine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 |
2003 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2005 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Terfenadine" by people in Profiles.
-
Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Ann Allergy Asthma Immunol. 2005 Jun; 94(6):662-9.
-
Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies. Pediatr Allergy Immunol. 2004 Jun; 15(3):253-60.
-
Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis. J Allergy Clin Immunol. 2003 Apr; 111(4):763-9.
-
A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1999 Nov; 104(5):1071-8.